Who owns GAIN THERAPEUTICS INC?
- Ticker: GANX
- CUSIP Number: 36269b105
Tip: Access positions for across all investors
Analyze quarterly positions in Gain Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Gain Therapeutics stock
Who bought or sold GAIN THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Greenlight Capital | 588k | $1.9M | 0% | Dec 2023 |
|
| Raymond James & Associates | 260k | $980k | 993% | Mar 2024 |
|
| Royal Bank of Canada | 200k | $808k | -5% | Dec 2023 |
|
| CM Management | 90k | $294k | 0% | Dec 2023 |
|
| Vanguard Group | 88k | $289k | 26% | Dec 2023 |
|
| Citadel Advisors | 74k | $241k | 43% | Dec 2023 |
|
| Dimensional Fund Advisors | 16k | $52k | -6% | Dec 2023 |
|
| UBS Group | 14k | $46k | 69% | Dec 2023 |
|
| Millennium Management | 13k | $42k | 100% | Dec 2023 |
|
| Advisor Group Holdings | 10k | $33k | 0% | Dec 2023 |
|
| Creekmur Asset Management | 4.4k | $15k | 100% | Dec 2023 |
|
| Wells Fargo & Company | 3.7k | $12k | 0% | Dec 2023 |
|
Who sold out of Gain Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Simplex Trading | Sep 2023 | 8.7k | $28k |